Ciprofloxacin-based ionic liquids demonstrate increased mutation frequency in Escherichia coli
Patrick Mester, Birgit Bromberger, Timea Dömök, Daniela Zetner, Laura Schleifer, Olga Makarova
This study shows that ciprofloxacin-based API-ILs increase mutation frequency in E. coli, while similar chloride ILs do not, highlighting potential risks of API-ILs in promoting bacterial resistance.
bioRxiv · Sep 29, 2025 · PreprintMicrobiology